Enrollment in Moderna's Covid-19 vaccine trial to complete by end of summer: Fauci | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Sunday
October 01, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
SUNDAY, OCTOBER 01, 2023
Enrollment in Moderna's Covid-19 vaccine trial to complete by end of summer: Fauci

Coronavirus chronicle

Reuters
27 July, 2020, 09:40 pm
Last modified: 27 July, 2020, 09:43 pm

Related News

  • Moderna ties up with Immatics to boost cancer vaccine development
  • Moderna says updated Covid vaccine is effective against newer variant
  • Cancer and heart disease vaccines expected to be ready by 2030
  • Moderna reports positive results for RSV vaccine
  • Moderna refused China request to reveal vaccine technology: Financial Times

Enrollment in Moderna's Covid-19 vaccine trial to complete by end of summer: Fauci

Data readouts from the trial, which enrolled the first of 30,000 trial participants on Monday, could occur by November or even earlier

Reuters
27 July, 2020, 09:40 pm
Last modified: 27 July, 2020, 09:43 pm
File Photo: Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a Senate Health, Education, Labor and Pensions Committee hearing on efforts to get back to work and school during the coronavirus disease (Covid-19) outbreak, in Washington, DC, US June 30, 2020. Photo : Reuters
File Photo: Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a Senate Health, Education, Labor and Pensions Committee hearing on efforts to get back to work and school during the coronavirus disease (Covid-19) outbreak, in Washington, DC, US June 30, 2020. Photo : Reuters

The top US infectious diseases expert Dr Anthony Fauci said on Monday enrollment in Moderna Inc's late-stage Covid-19 vaccine trial is expected to be finished by the end of summer this year.

Data readouts from the trial, which enrolled the first of 30,000 trial participants on Monday, could occur by November or even earlier, Fauci said in a media call discussing the late-stage study.

Moderna / Coronavirus Vaccine Trial

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Containers piled up at Chattogram port. File Photo: TBS
    Exports fetch $4.31 billion in September, lowest since April
  • Remittance earnings in September lowest in 41 months
    Remittance earnings in September lowest in 41 months
  • Photo: UNB
    No discussion held on visa policy with US Assistant Secretary Bitter: Acting Foreign Secretary

MOST VIEWED

  • Photo: TBS
    Habibur Rahman takes charge as 36th DMP commissioner
  • Paperfly aborts flight
    Paperfly aborts flight
  • Photo: Collected
    The top 3 smartwatches of 2023: A glimpse into the future
  • Photo: TBS
    Dhaka traffic slowest in world: Study
  • Harsher bilateral loans set to make external debt repayment tougher
    Harsher bilateral loans set to make external debt repayment tougher
  • Illustration: TBS
    Shokh and Sarika’s quest of return

Related News

  • Moderna ties up with Immatics to boost cancer vaccine development
  • Moderna says updated Covid vaccine is effective against newer variant
  • Cancer and heart disease vaccines expected to be ready by 2030
  • Moderna reports positive results for RSV vaccine
  • Moderna refused China request to reveal vaccine technology: Financial Times

Features

Illustration: Collected

Apology to a life forgotten to live

2h | Features
Photo: Kazi Ashraf Uddin

Coffee: More than a beverage, something of a beloved

5h | Features
The price back to the normal range is possible if the corporations who control the feed market reduce the feed and chick prices. Photo: Noor-A-Alam

Will eggs ever return to their 'normal' price?

7h | Features
Photo & Coffee Sketch: Touseful Isalm

A coffee conversation with Rumi

1d | Features

More Videos from TBS

Apple is bringing new software updates to prevent overheating

Apple is bringing new software updates to prevent overheating

1h | Tech Talk
A unique study cafe in the city

A unique study cafe in the city

49m | TBS Stories
Reserves are falling even as the dollar's share of global payments rises

Reserves are falling even as the dollar's share of global payments rises

4h | TBS Economy
Why is the remittance of banks increasing or decreasing?

Why is the remittance of banks increasing or decreasing?

2h | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]